Search

Clinical Articles / BY: Christine E. Simmons, MD, MSc, FRCPC March 2018
... positivity be considered candidates for chemotherapy.[ 4 ] In recent years, the use of systemic therapy in the ... in operable, earlier stage disease for several reasons.[ 4 ] The only true head-to-head comparison of neoadjuvant ... therapy could be considered for neoadjuvant therapy.[ 4 ] Patient selection Several guideline committees have ...
Editorials / BY: Rona E. Cheifetz, MD, MEd, FRCSC, FACS March 2018
... attributed to a combination of screening and treatment.[ 3,4 ] An increasing range of treatment options are available ...
Letters / BY: David Kendler, MD March 2018
... 34.6% of patients on placebo. Infections occurred in 54.4% of placebo patients and 52.9% of denosumab-treated ... Serious adverse events of infections were reported in 3.4% of placebo subjects and 4.1% of denosumab subjects ( P  = 0.14). The references ...
Letters / BY: James M. Wright, MD, PhD, FRCPC March 2018
...  editors.  Dr Kendler cites a single trial[ 4 ] and relative risk reductions, which are well known to be ...
MDs To Be / BY: Ryan Danroth, BSc March 2018
... lack of harm reduction supplies such as sterile syringes.[ 4 ] Injection materials are often shared multiple times over ...
Obituaries / BY: Alan Burris, MD March 2018
... Stewart loved the practice of medicine, and over the next 4 decades he delighted in providing medical care to the ...
Council on Health Promotion / BY: Jay Slater, MD January/February 2018
... will diminish the moral quality and standard of care.[ 4 ] As assistive technology expands, so does the field of ...
Letters / BY: Alexandra Choi, MD, MHSc, CCFP January/February 2018
... programs. Within Canada, Quebec has already adopted HiAP.[ 4 ] Farther from home, Scandinavian countries have seen ...
Letters / BY: Sandra Seo Young Kim, BSc January/February 2018
... teamwork into a future practitioner’s practice,[ 4 ] the CHIUS clinic addresses a gap that currently exists in ...
Letters / BY: Sarah Fraser, BSc January/February 2018
... of the nomenclature continues to be debated.[ 4 ] The terms may convey altered messages to patients, and it ... the transient nature of impaired neurological function.[ 4 ] A negative illness perception in mTBI patients results in ...